Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 11.44M
March 31, 2026 26.10M
December 31, 2025 31.80M
September 30, 2025 37.59M
June 30, 2025 41.85M
March 31, 2025 43.70M
December 31, 2024 43.54M
September 30, 2024 41.78M
June 30, 2024 40.28M
March 31, 2024 38.76M
December 31, 2023 40.33M
September 30, 2023 43.72M
June 30, 2023 45.04M
March 31, 2023 44.03M
December 31, 2022 41.33M
September 30, 2022 37.92M
June 30, 2022 35.91M
March 31, 2022 35.60M
December 31, 2021 33.71M
September 30, 2021 32.98M
June 30, 2021 29.72M
March 31, 2021 27.48M
December 31, 2020 26.81M
September 30, 2020 25.23M
June 30, 2020 23.84M
Date Value
March 31, 2020 22.87M
December 31, 2019 22.90M
September 30, 2019 22.26M
June 30, 2019 21.96M
March 31, 2019 19.20M
December 31, 2018 16.36M
September 30, 2018 13.34M
June 30, 2018 12.77M
March 31, 2018 12.08M
December 31, 2017 11.32M
September 30, 2017 10.67M
June 30, 2017 11.17M
March 31, 2017 9.792M
December 31, 2016 8.626M
September 30, 2016 7.254M
June 30, 2016 3.662M
March 31, 2016 3.544M
December 31, 2015 2.624M
September 30, 2015 2.272M
June 30, 2015 1.869M
March 31, 2015 1.335M
December 31, 2014 1.046M
September 30, 2014 0.7324M
June 30, 2014 0.4856M
March 31, 2014 0.2596M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Vaxcyte, Inc. 1.093B
Foghorn Therapeutics, Inc. 76.22M
Connect Biopharma Holdings Ltd. 55.37M
Caribou Biosciences, Inc. 84.72M
Oncolytics Biotech, Inc. 13.18M